It is a pharma private limited company based in Palakkad, Kerala, India, established in 2022.
2022 | Palakkad, Kerala, India | ActiveNew Viswabharathy Drug Lines Private Limited, a active private limited company, was established on 06 May 2022 in Palakkad, Kerala, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24299KL2022PTC075397. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Narasaiah Arigela (Director), Anish Anamala Akbar (Managing Director), Ahammed Faizal Ismail (Director). Past directors included Narasaiah Arigela. It holds ₹8.00 Cr open charges and no settled loans. Its latest AGM occurred on 11 July 2025, with the balance sheet filed on 31 March 2025. It is based at 41/1561(1) To 41/1561(7), Ground Floor And First Floor, Land Mark Building Ma Road, Palakkad, Kerala, 678014.
U24299KL2022PTC075397
075397
06 May 2022
₹1.50 M
₹1.50 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into New Viswabharathy Drug Lines Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Narasaiah Arigela | Director | 05 Jul 2024 | Current |
| Anish Anamala Akbar | Managing Director | 06 May 2022 | Current |
| Ahammed Faizal Ismail | Director | 06 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Sep 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
New Viswabharathy Drug Lines Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to New Viswabharathy Drug Lines's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹80,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Aug 2024 | Hdfc Bank Limited | ₹8.00 Cr | Open |
Explore comprehensive loan charge details -
New Viswabharathy Drug Lines has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of New Viswabharathy Drug Lines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Viswabharathy Drug Lines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity New Viswabharathy Drug Lines Private Limited last Annual general meeting of members was held on 11 Jul 2025 as per latest MCA records. was completed.
The activity New Viswabharathy Drug Lines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 80.00 M with Charge ID 100977521 was registered on 14 Aug 2024. was recorded as a recent event.
The activity Narasaiah Arigela was appointed as a Director was appointed as a Director on 05 Jul 2024 & has been associated with this company since 1 year 4 months . was completed.
Progress on Anish Anamala Akbar was appointed as a Managing Director was appointed as a Managing Director on 06 May 2022 & has been associated with this company since 3 years 6 months . was documented.
The activity Ahammed Faizal Ismail was appointed as a Director was appointed as a Director on 06 May 2022 & has been associated with this company since 3 years 6 months . was completed.
The CIN of New Viswabharathy Drug Lines Private Limited is U24299KL2022PTC075397.
New Viswabharathy Drug Lines Private Limited is headquartered at 41/1561(1) To 41/1561(7), Ground Floor And First Floor, Land Mark Building Ma Road, Palakkad, Kerala, 678014.
New Viswabharathy Drug Lines Private Limited was incorporated on 06 May 2022.
The current directors of New Viswabharathy Drug Lines Private Limited are
The primary industry of New Viswabharathy Drug Lines Private Limited is Trade.
New Viswabharathy Drug Lines Private Limited is unlisted.
The authorized capital of New Viswabharathy Drug Lines Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
The compliance status of New Viswabharathy Drug Lines Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX